AngioDynamics Announces FDA Clearance of Expanded Indications for Auryon Atherectomy System
The United States Food and Drug Administration (FDA) recently cleared the expanded indication for the Auryon System’s 2.0mm and 2.35mm catheters to include adjacent thrombus aspiration when treating stenoses in native and stented infrainguinal arteries. Both catheters have aspiration capabilities as atherectomy devices, including in-stent restenosis (ISR).
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
Lead with Confidence. Attack with Control.
The AlphaVac system is an off the shelf, easy to assemble, emergent mechanical aspiration device, allowing for efficient procedure time…
NanoKnife 3.0 System
Your Treatment. Reimagined.
Today, localized therapy options are limited in providing physicians and patients with a customizable and confident treatment. Most options come…
Introducing the Next Generation of Peripheral Atherectomy Technology
Engineered with your practice and your patients in mind, The Auryon System is designed with industry-leading technology and features that…
Our Culture is Our Success
Become a proud member of our team
It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.
The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.
If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.